Literature DB >> 17475765

Comparison of immunoglobulin G responses to the spike and nucleocapsid proteins of severe acute respiratory syndrome (SARS) coronavirus in patients with SARS.

Jincun Zhao1, Wei Wang, Wenling Wang, Zhendong Zhao, Yan Zhang, Ping Lv, Furong Ren, Xiao-Ming Gao.   

Abstract

Both the nucleocapsid (N) and the spike (S) proteins of severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) are able to induce strong humoral responses in humans following an infection. To compare the immunoglobulin G (IgG) responses to the S and N proteins of SARS-CoV in SARS patients during the manifestation/convalescent period with those during the postinfection period, serum samples were collected from hospitalized SARS patients within 6 weeks after the onset of illness (set 1; 57 sequential samples from 19 patients) or 2 to 3 months after their recovery (set 2; 33 postinfection samples from 33 subjects). Serum samples from 100 healthy blood donors (set 3), collected in 2002, were also included. The specific IgG response to whole virus, the fragment from positions 450 to 650 of the S protein (S450-650), and the full-length N protein of SARS-CoV were measured by enzyme-linked immunosorbent assays (ELISAs). Western blot assays were carried out to confirm the ELISA results. Fifty-one of the serum samples in set 1 (89%) bound to the N protein, a proportion similar to that which recognized whole virus (79%) and the S-protein fragment (77%). All 33 serum samples from set 2 were strongly positive for N-protein-specific IgG, while 27 (82%) were positive for anti-S450-650 IgG. Two of the serum samples from set 3 were strongly positive for anti-N-protein IgG but not anti-S450-650 IgG. Similar levels of IgG responses to the S and N proteins were observed in SARS patients during the manifestation and convalescent stages. In the postinfection period, however, a number of patients had much lower serum IgG levels against S450-650 than against the N protein.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17475765      PMCID: PMC1951070          DOI: 10.1128/CVI.00432-06

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  21 in total

1.  Characterization of a novel coronavirus associated with severe acute respiratory syndrome.

Authors:  Paul A Rota; M Steven Oberste; Stephan S Monroe; W Allan Nix; Ray Campagnoli; Joseph P Icenogle; Silvia Peñaranda; Bettina Bankamp; Kaija Maher; Min-Hsin Chen; Suxiong Tong; Azaibi Tamin; Luis Lowe; Michael Frace; Joseph L DeRisi; Qi Chen; David Wang; Dean D Erdman; Teresa C T Peret; Cara Burns; Thomas G Ksiazek; Pierre E Rollin; Anthony Sanchez; Stephanie Liffick; Brian Holloway; Josef Limor; Karen McCaustland; Melissa Olsen-Rasmussen; Ron Fouchier; Stephan Günther; Albert D M E Osterhaus; Christian Drosten; Mark A Pallansch; Larry J Anderson; William J Bellini
Journal:  Science       Date:  2003-05-01       Impact factor: 47.728

2.  The Genome sequence of the SARS-associated coronavirus.

Authors:  Marco A Marra; Steven J M Jones; Caroline R Astell; Robert A Holt; Angela Brooks-Wilson; Yaron S N Butterfield; Jaswinder Khattra; Jennifer K Asano; Sarah A Barber; Susanna Y Chan; Alison Cloutier; Shaun M Coughlin; Doug Freeman; Noreen Girn; Obi L Griffith; Stephen R Leach; Michael Mayo; Helen McDonald; Stephen B Montgomery; Pawan K Pandoh; Anca S Petrescu; A Gordon Robertson; Jacqueline E Schein; Asim Siddiqui; Duane E Smailus; Jeff M Stott; George S Yang; Francis Plummer; Anton Andonov; Harvey Artsob; Nathalie Bastien; Kathy Bernard; Timothy F Booth; Donnie Bowness; Martin Czub; Michael Drebot; Lisa Fernando; Ramon Flick; Michael Garbutt; Michael Gray; Allen Grolla; Steven Jones; Heinz Feldmann; Adrienne Meyers; Amin Kabani; Yan Li; Susan Normand; Ute Stroher; Graham A Tipples; Shaun Tyler; Robert Vogrig; Diane Ward; Brynn Watson; Robert C Brunham; Mel Krajden; Martin Petric; Danuta M Skowronski; Chris Upton; Rachel L Roper
Journal:  Science       Date:  2003-05-01       Impact factor: 47.728

3.  Profile of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome (SARS)-associated coronavirus in probable SARS patients.

Authors:  Xuan Liu; Yulin Shi; Ping Li; Linhai Li; Yanping Yi; Qingjun Ma; Cheng Cao
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

4.  The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor.

Authors:  Haitao Yang; Maojun Yang; Yi Ding; Yiwei Liu; Zhiyong Lou; Zhe Zhou; Lei Sun; Lijuan Mo; Sheng Ye; Hai Pang; George F Gao; Kanchan Anand; Mark Bartlam; Rolf Hilgenfeld; Zihe Rao
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-29       Impact factor: 11.205

5.  Coronavirus as a possible cause of severe acute respiratory syndrome.

Authors:  J S M Peiris; S T Lai; L L M Poon; Y Guan; L Y C Yam; W Lim; J Nicholls; W K S Yee; W W Yan; M T Cheung; V C C Cheng; K H Chan; D N C Tsang; R W H Yung; T K Ng; K Y Yuen
Journal:  Lancet       Date:  2003-04-19       Impact factor: 79.321

6.  A study on antigenicity and receptor-binding ability of fragment 450-650 of the spike protein of SARS coronavirus.

Authors:  Jincun Zhao; Wei Wang; Zhihong Yuan; Rujing Jia; Zhendong Zhao; Xiaojun Xu; Ping Lv; Yan Zhang; Chengyu Jiang; Xiao-Ming Gao
Journal:  Virology       Date:  2006-10-20       Impact factor: 3.616

7.  The SARS-CoV S glycoprotein: expression and functional characterization.

Authors:  Xiaodong Xiao; Samitabh Chakraborti; Anthony S Dimitrov; Kosi Gramatikoff; Dimiter S Dimitrov
Journal:  Biochem Biophys Res Commun       Date:  2003-12-26       Impact factor: 3.575

8.  Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.

Authors:  Wenhui Li; Michael J Moore; Natalya Vasilieva; Jianhua Sui; Swee Kee Wong; Michael A Berne; Mohan Somasundaran; John L Sullivan; Katherine Luzuriaga; Thomas C Greenough; Hyeryun Choe; Michael Farzan
Journal:  Nature       Date:  2003-11-27       Impact factor: 49.962

9.  Mass spectrometric characterization of proteins from the SARS virus: a preliminary report.

Authors:  Oleg Krokhin; Yan Li; Anton Andonov; Heinz Feldmann; Ramon Flick; Steven Jones; Ute Stroeher; Nathalie Bastien; Kumar V N Dasuri; Keding Cheng; J Neil Simonsen; Hélène Perreault; John Wilkins; Werner Ens; Frank Plummer; Kenneth G Standing
Journal:  Mol Cell Proteomics       Date:  2003-05-29       Impact factor: 5.911

10.  A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2.

Authors:  Swee Kee Wong; Wenhui Li; Michael J Moore; Hyeryun Choe; Michael Farzan
Journal:  J Biol Chem       Date:  2003-12-11       Impact factor: 5.157

View more
  13 in total

1.  Differentiation between human coronaviruses NL63 and 229E using a novel double-antibody sandwich enzyme-linked immunosorbent assay based on specific monoclonal antibodies.

Authors:  Patricia Sastre; Ronald Dijkman; Ana Camuñas; Tamara Ruiz; Maarten F Jebbink; Lia van der Hoek; Carmen Vela; Paloma Rueda
Journal:  Clin Vaccine Immunol       Date:  2010-11-17

2.  Human coronavirus NL63 and 229E seroconversion in children.

Authors:  Ronald Dijkman; Maarten F Jebbink; Nawal Bahia El Idrissi; Krzysztof Pyrc; Marcel A Müller; Taco W Kuijpers; Hans L Zaaijer; Lia van der Hoek
Journal:  J Clin Microbiol       Date:  2008-05-21       Impact factor: 5.948

3.  Characterization of anti-MERS-CoV antibodies against various recombinant structural antigens of MERS-CoV in an imported case in China.

Authors:  Wenling Wang; Huijuan Wang; Yao Deng; Tie Song; Jiaming Lan; Guizhen Wu; Changwen Ke; Wenjie Tan
Journal:  Emerg Microbes Infect       Date:  2016-11-09       Impact factor: 7.163

4.  Development of a Whole-Virus ELISA for Serological Evaluation of Domestic Livestock as Possible Hosts of Human Coronavirus NL63.

Authors:  Philip El-Duah; Benjamin Meyer; Augustina Sylverken; Michael Owusu; Lina Theresa Gottula; Richmond Yeboah; Jones Lamptey; Yaw Oppong Frimpong; Vitus Burimuah; Raphael Folitse; Olivia Agbenyega; Samuel Oppong; Yaw Adu-Sarkodie; Christian Drosten
Journal:  Viruses       Date:  2019-01-09       Impact factor: 5.048

5.  A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity.

Authors:  Angkana T Huang; Bernardo Garcia-Carreras; Matt D T Hitchings; Bingyi Yang; Leah C Katzelnick; Susan M Rattigan; Brooke A Borgert; Carlos A Moreno; Benjamin D Solomon; Luke Trimmer-Smith; Veronique Etienne; Isabel Rodriguez-Barraquer; Justin Lessler; Henrik Salje; Donald S Burke; Amy Wesolowski; Derek A T Cummings
Journal:  Nat Commun       Date:  2020-09-17       Impact factor: 14.919

Review 6.  A Minimalist Strategy Towards Temporarily Defining Protection for COVID-19.

Authors:  Nevio Cimolai
Journal:  SN Compr Clin Med       Date:  2020-09-19

7.  How Useful is COVID-19 Antibody Testing - A Current Assessment for Oncologists.

Authors:  P A C Maple; K Sikora
Journal:  Clin Oncol (R Coll Radiol)       Date:  2020-10-13       Impact factor: 4.126

8.  Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection.

Authors:  Susanna K Elledge; Xin X Zhou; James R Byrnes; Alexander J Martinko; Irene Lui; Katarina Pance; Shion A Lim; Jeff E Glasgow; Anum A Glasgow; Keirstinne Turcios; Nikita Iyer; Leonel Torres; Michael J Peluso; Timothy J Henrich; Taia T Wang; Cristina M Tato; Kevin K Leung; Bryan Greenhouse; James A Wells
Journal:  medRxiv       Date:  2020-08-21

9.  ReScan, a Multiplex Diagnostic Pipeline, Pans Human Sera for SARS-CoV-2 Antigens.

Authors:  Colin R Zamecnik; Jayant V Rajan; Kevin A Yamauchi; Sabrina A Mann; Rita P Loudermilk; Gavin M Sowa; Kelsey C Zorn; Bonny D Alvarenga; Christian Gaebler; Marina Caskey; Mars Stone; Philip J Norris; Wei Gu; Charles Y Chiu; Dianna Ng; James R Byrnes; Xin X Zhou; James A Wells; Davide F Robbiani; Michel C Nussenzweig; Joseph L DeRisi; Michael R Wilson
Journal:  Cell Rep Med       Date:  2020-09-24

Review 10.  Applying Immune Instincts and Maternal Intelligence from Comparative Microbiology to COVID-19.

Authors:  Nevio Cimolai
Journal:  SN Compr Clin Med       Date:  2020-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.